tirzepatide and menopause plus hormone therapy aids weight loss Menopause: GLP-1 Drugs, Hormone Therapy

Semaglutide monotherapy has demonstrated consistent weight loss of 1022% over 68 weeks in trials like STEP 1 and STEP 2, without requiring additional sympathomimetic agents

10.5455/jice.20150314061404 34 JohnyJ.BhagvandasS

Cold sores or genital herpes: Among over 12,000 supplement-related ED consultations logged by Allo Health, less than 4% of users reported mild side effects like bloating or headaches, most of which resolved by lowering the dose

No, not for adults 21 and older as of January 1, 2026

However, any combination of compounds should be discussed with a healthcare provider who understands both your neuropathy treatment and the peptides you are considering

Therefore, this hormone could be a promising candidate for combination therapy with GLP-1 for better control of T2D